AtaiBeckley jumps as market reports say Eli Lilly is considering an acquisition
Shares of the psychedelics-focused biotech AtaiBeckley surged in premarket trading after reports that Eli Lilly is in discussions about a potential deal, sending momentum into a space that has attracted both scientific and commercial interest.